FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 54 filers reported holding FATE THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $169,000 | -17.2% | 67,239 | +2.6% | 0.00% | – |
| Q3 2016 | $204,000 | +59.4% | 65,539 | -13.3% | 0.00% | – |
| Q2 2016 | $128,000 | +18.5% | 75,572 | +26.2% | 0.00% | – |
| Q1 2016 | $108,000 | -50.5% | 59,871 | -7.3% | 0.00% | – |
| Q4 2015 | $218,000 | -34.5% | 64,611 | +3.3% | 0.00% | – |
| Q3 2015 | $333,000 | -19.8% | 62,538 | -2.6% | 0.00% | – |
| Q2 2015 | $415,000 | +277.3% | 64,194 | +186.5% | 0.00% | – |
| Q1 2015 | $110,000 | -8.3% | 22,406 | -6.4% | 0.00% | – |
| Q4 2014 | $120,000 | +6.2% | 23,926 | +7.7% | 0.00% | – |
| Q3 2014 | $113,000 | -24.7% | 22,216 | -6.8% | 0.00% | – |
| Q2 2014 | $150,000 | -33.3% | 23,831 | +2.9% | 0.00% | – |
| Q1 2014 | $225,000 | – | 23,151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 716,392 | $11,126,000 | 12.18% |
| Polaris Venture Management Co. V, L.L.C. | 1,139,783 | $17,701,000 | 10.06% |
| Grosvenor Holdings, L.L.C. | 2,285,714 | $35,497,000 | 6.41% |
| Redmile Group, LLC | 11,216,809 | $174,197,000 | 5.83% |
| Casdin Capital, LLC | 2,550,000 | $39,601,500,000 | 4.10% |
| DAFNA Capital Management LLC | 470,000 | $7,299,000 | 2.74% |
| Ghost Tree Capital, LLC | 350,000 | $5,436,000 | 1.38% |
| Artal Group S.A. | 2,000,000 | $31,060,000 | 1.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,952,897 | $30,328,000 | 1.24% |
| Copernicus Capital Management, LLC | 75,000 | $1,165,000 | 1.08% |